Novartis Ag (NVS) Short term Debt (2009 - 2026)
Novartis Ag (NVS) posted Short term Debt of $37.49 billion for Q2 2026, up 66.8% from $22.47 billion a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Short term Debt (2009 - 2026) Analysis & Trends
At the end of FY2025, Novartis Ag's Short term Debt came in at $27.94 billion, up 30.7% from FY2024.
- Annual Short term Debt shows a five-year compound annual growth rate of 1.2% (FY2020 to FY2025).
- In prior years, Novartis Ag's Short term Debt was $21.37 billion in FY2024 (+15.9%), $18.44 billion in FY2023 (-8.9%), $20.24 billion in FY2022 (+221.6%) and $6.3 billion in FY2021 (-76.0%).
- The Q2 2026 figure stands as the highest quarterly Short term Debt in data going back to Q1 2009.
- On a year-over-year basis, Short term Debt has increased in each of the last three quarters, with growth averaging 31.7% over the last eight quarters.
- The strongest year-over-year quarter for Short term Debt in the past five years was Q4 2022, with growth of 221.6%; the weakest was Q4 2021, with a decline of 76.0%.
- According to Business Quant data, Short term Debt for the three prior quarters was $37.45 billion (Q1 2026), $27.94 billion (Q4 2025) and $22.6 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 135.58 Bn | 107.59 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.59 Bn |
| Mar 31, 2026 | 7.62 Bn |
| Dec 31, 2025 | 5.60 Bn |
| Sep 30, 2025 | 7.52 Bn |
| Jun 30, 2025 | 8.31 Bn |
| Mar 31, 2025 | 7.80 Bn |
| Dec 31, 2024 | 8.23 Bn |
| Sep 30, 2024 | 6.57 Bn |
| Jun 30, 2024 | 7.53 Bn |
| Mar 31, 2024 | 8.34 Bn |
| Dec 31, 2023 | 6.18 Bn |
| Sep 30, 2023 | 5.46 Bn |
| Jun 30, 2023 | 8.29 Bn |
| Mar 31, 2023 | 6.97 Bn |
| Dec 31, 2022 | 5.93 Bn |
| Sep 30, 2022 | 7.06 Bn |
| Jun 30, 2022 | 7.05 Bn |
| Mar 31, 2022 | 6.70 Bn |
| Dec 31, 2021 | 6.30 Bn |
| Sep 30, 2021 | 9.34 Bn |
API Access
Novartis Ag Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();